Delivery Order SPE2DB22D3016-SPE2DB25FATJ3
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,138.25, is a delivery order for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.25 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through March 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,325.28 delivery order contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a period of performance through October 4, 2023. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The federal contract award, with ID SPE2DB20D3103/SPE2DB22FP2V7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,590.90 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with an ultimate completion date of August 12, 2022. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,221.00 firm fixed-price delivery order covers the provision of RHOGAM ULTRA-FILTERED PLUS SYRS, a critical medical product, with a performance period through December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,731.80, is a Firm Fixed Price Delivery Order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.24 delivery order contract is for the supply of Rhogam Ultra-Filtered Plus syringes, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of October 21, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award, valued at $2,832.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a completion date of July 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA Troop Support Medical valued up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rhogam Ultra-Filtered Plus Syringes, a specialty pharmaceutical product, with a ceiling value of $1,652.28. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is November 13, 2024. This award is not designated as a set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.40, is a delivery order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialty medical product. The contract has a firm-fixed price and an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FATJ3Delivery Order
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FATJ3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,938.72 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a performance period ending on April 29, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award is not designated as a set-aside and allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 4/8/25 |